TÜV Rheinland Becomes 5th Notified Body Designated Under MDR

Europe – Règlement d’exécution (UE) 2024/2699 de la Commission du 18 octobre 2024

LA COMMISSION EUROPÉENNE, vu le traité sur le fonctionnement de l’Union européenne, vu le règlement (UE) 2021/2282 du Parlement européen et du Conseil du 15 décembre 2021 concernant...

Europe – Open letter to Stella Kyriakides on the urgent need for action on...

On 14 October 2024, together with 39 national associations, MedTech Europe has sent an open letter to European Commissioner for Health & Food Safety,...

Europe – MDCG 2021-25 Rev. 1 Regulation (EU) 2017/745 – application of MDR requirements...

The transitional provisions of Regulation (EU) 2017/745 on medical devices (MDR) have been amended by Regulation (EU) 2023/607. In particular, the transitional period has been extended...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – MHRA to launch consultation on device international reliance plan by year’s end

The UK Medicines and Healthcare products Regulatory Agency (MHRA) plans to publish a public consultation on a proposal to allow medical devices automatic access...
TÜV Rheinland Becomes 5th Notified Body Designated Under MDR

Europe – Commission Implementing Decision (EU) 2024/2625 of 8 October 2024 amending Implementing Decision...

THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 1025/2012 of the European Parliament and...
TÜV Rheinland Becomes 5th Notified Body Designated Under MDR

Europe – Commission Implementing Decision (EU) 2024/2631 of 8 October 2024 amending Implementing Decision...

THE EUROPEAN COMMISSION, Having regard to the Treaty on the Functioning of the European Union, Having regard to Regulation (EU) No 1025/2012 of the European Parliament and...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – MDCG 2024-11 Guidance on qualification of in vitro diagnostic medical devices

The purpose of this guidance document is to clarify what products fall in scope of Regulation 2017/746 on in vitro diagnostic medical devices (IVDR)...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – MDCG 2024-12 Corrective and preventive action (CAPA) plan assessment: guidance and templates...

This guidance document is intended for conformity assessment bodies (CABs), notified bodies (NBs), designating authorities (DAs), and Joint Assessment Teams (JATs) involved in Regulation (EU) 2017/745...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – MHRA e-cigarette and vape products regulator profile

The information below contains the contact details and responsibilities of each of the regulatory bodies involved in the regulation of e-cigarette and vape products...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – An update on our plans for Med Tech regulatory change

Our external engagement on the programme of regulatory changes for medical devices has re-started in earnest this week following the pre-election period and early...

NOS PROCHAINES FORMATIONS